Park Avenue Securities’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,309
| Closed | -$268K | – | 1582 |
|
|
2025
Q1 | $268K | Buy |
+3,309
| New | +$268K | ﹤0.01% | 1037 |
|
|
2024
Q4 | – | Sell |
-46,989
| Closed | -$4.64M | – | 1524 |
|
|
2024
Q3 | $4.64M | Buy |
46,989
+43,417
| +1,215% | +$4.29M | 0.05% | 239 |
|
|
2024
Q2 | $331K | Buy |
+3,572
| New | +$331K | ﹤0.01% | 1150 |
|
|
2023
Q1 | – | Sell |
-3,521
| Closed | -$292K | – | 1177 |
|
|
2022
Q4 | $292K | Buy |
3,521
+305
| +9% | +$25.3K | 0.01% | 994 |
|
|
2022
Q3 | $255K | Buy |
3,216
+492
| +18% | +$39K | 0.01% | 976 |
|
|
2022
Q2 | $202K | Buy |
+2,724
| New | +$202K | ﹤0.01% | 1062 |
|